Exactly Sox....I am speculating that the funding will be used to pay the P CRO to provide the results, K oral formulation development and perhaps the B sachets for B-OM, which was likely ongoing with Evonik and the other manufacturer. Not nearly enough to go it alone into Phase III. Great response!